Androgenetic alopecia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Chinese adult males aged 18-50; 2.Patients clinically diagnosed with androgenetic alopecia and classified as Hamilton-Norwood grades IIIv, IV, and V; 3.The scalp is healthy, with no severe skin diseases or infections; 4.The subjects are willing to maintain the same hairstyle, hair color, and hair length during each follow-up visit; 5.Sign the informed consent form, indicating willingness to participate in the study and abide by the study regulations.
Exclusion criteria
Exclusion criteria: 1.Cannot tolerate laser treatment; 2.Individuals who are allergic to minoxidil; 3.Individuals with severe heart, liver, kidney diseases, or mental disorders; 4.Individuals who have recently undergone other treatments for hair loss (having taken oral finasteride within the 18 months prior to study screening, taken oral finasteride within the past year, or used topical medications with hair growth effects such as minoxidil within the past six months); 5.Men who plan to have children in the near future; 6.Those who cannot cooperate with the research or follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Terminal Hair Count in the Target Area (TAHC); | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in Patient Disease Grading;Self-Rating of Study Participant Satisfaction;Changes in the Ratio of Terminal Hair to Vellus Hair in the Target Area;TAHC (Terminal Hair Count) Change Rate;Average Change in TAHC; | — |
Countries
China
Contacts
Peking University People’s Hospital